Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRódenas-Alesina, Eduard
dc.contributor.authorBadia Molins, Clara
dc.contributor.authorVila, Rosa
dc.contributor.authorCalvo-Barceló, Maria
dc.contributor.authorFernández Galera, Ruben
dc.contributor.authorFerreira González, Ignacio
dc.contributor.authorLozano Torres, Jordi
dc.contributor.authorTobías-Castillo, Pablo Eduardo
dc.contributor.authorCasas, Guillem
dc.contributor.authorSoriano Colomé, Toni
dc.contributor.authorOlivella, Aleix
dc.contributor.authorMéndez Fernández, Ana Belén
dc.contributor.authorBarrabés, José A.
dc.contributor.authorRodríguez Palomares, José F
dc.date.accessioned2024-10-14T12:40:21Z
dc.date.available2024-10-14T12:40:21Z
dc.date.issued2024-06-25
dc.identifier.citationRódenas-Alesina E, Lozano-Torres J, Tobías-Castillo PE, Badia-Molins C, Vila-Olives R, Calvo-Barceló M, et al. Left atrial deformation analysis in patients with non-ischaemic dilated cardiomyopathy in atrial fibrillation. Eur Hear J - Imaging Methods Pract. 2024 Jan 25;2(1):qyae063.
dc.identifier.issn2755-9637
dc.identifier.urihttps://hdl.handle.net/11351/12060
dc.descriptionEchocardiography; Left atrial strain; Non-ischaemic dilated cardiomyopathy
dc.description.abstractAims Atrial fibrillation (AF) is a common comorbidity in non-ischaemic dilated cardiomyopathy (NIDCM) affecting conventional measures of left atrial (LA) function. We aimed to determine whether LA function analysis could identify patients at higher risk of major cardiovascular events (MACEs). Methods and results A retrospective study of patients with NIDCM in AF referred to a single centre for transthoracic echocardiography (TTE) between 2015 and 2019. Peak atrial longitudinal strain (PALS) was measured along with LA emptying fraction and LA filling index (LAFI = E wave/PALS). Cox regression analysis was conducted. A total of 153 patients were included [median age 74 years, left ventricular ejection fraction (LVEF) 35%], and 57 (37.3%) had MACE after a median follow-up of 3.2 years. LAFI was the only independent TTE parameter associated with MACE after adjustment for age, diabetes, LVEF, left ventricular global longitudinal strain (LV-GLS), and LA volume index [adjusted hazard ratio (HR) = 1.02 per point increase, P = 0.024], with the best cut-off at ≥15. LAFI ≥15 predicted each of MACE components when separately analysed: MACE HR = 1.95, 95% confidence interval (CI) 1.16–3.30; cardiovascular death HR = 3.68, 95% CI 1.41–9.56, heart failure admission HR = 2.13, 95% CI 1.19–3.80, and ventricular arrhythmia HR = 4.72, 95% CI 1.52–14.67. Higher LAFI was associated with worsening LV-GLS, E/e′, systolic pulmonary artery (PA) pressure, tricuspid annular plane systolic excursion, and right ventricular to PA coupling. Conclusion LA deformation analysis is feasible in patients with NIDCM presenting with AF. LAFI may identify patients at higher risk of MACE and correlates with higher pulmonary pressures and worse right ventricular function, suggesting an elevation of left-sided ventricular pressures in patients with higher LAFI.
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.ispartofseriesEuropean Heart Journal - Imaging Methods and Practice;2(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectEcocardiografia
dc.subjectFibril·lació auricular
dc.subjectMiocardi - Malalties
dc.subjectComorbiditat
dc.subjectAurícula
dc.subject.meshCardiomyopathy, Dilated
dc.subject.meshAtrial Fibrillation
dc.subject.meshComorbidity
dc.subject.meshAtrial Function, Left
dc.subject.meshEchocardiography
dc.titleLeft atrial deformation analysis in patients with non-ischaemic dilated cardiomyopathy in atrial fibrillation
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1093/ehjimp/qyae063
dc.subject.decsmiocardiopatía dilatada
dc.subject.decsfibrilación atrial
dc.subject.decscomorbilidad
dc.subject.decsfunción del atrio izquierdo
dc.subject.decsecocardiografía
dc.relation.publishversionhttps://doi.org/10.1093/ehjimp/qyae063
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Ródenas-Alesina E, Lozano-Torres J, Tobías-Castillo PE, Badia-Molins C, Vila-Olives R, Calvo-Barceló M, Casas G, Soriano-Colomé T, San Emeterio AO, Fernández-Galera R, Méndez-Fernández AB] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Barrabés JA, Rodríguez-Palomares J] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Madrid, Spain. [Ferreira-González I] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain
dc.identifier.pmid39224100
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record